Mr. King (Drew) is a Partner and the Chief Financial Officer of Cure Ventures. He oversees the financial and operational functions at the Firm and our early-stage portfolio companies. Drew has over 15 years of experience in finance and operations supporting both private and capital market funds.
He most recently was the Vice President of Finance at Bain Capital, helping launch the Life Sciences and Double Impact business units in 2016. Prior to that he was a Finance Manager at Absolute Return Capital, a global macro hedge fund, assisting in the day-to-day oversight for all post-trade activities. He spent 7 years in public accounting at Ernst & Young within the Financial Services Office focusing on venture capital, private equity, and hedge fund clients.
Drew received a M.S.A. from the University of Virginia, McIntire School of Commerce and a B.S. in Corporate Finance and Accounting from Bentley University and is a Certified Public Accountant.